My watch list
my.bionity.com  
Login  

372 Current news of Merck

rss

You can refine your search further. Select from the filter options on the left to narrow down your results.

Merck Generates Profitable Growth in Q3 2019

15-Nov-2019

Merck generated strong organic sales growth and benefited from positive foreign exchange effects in the third quarter of 2019. EBITDA pre increased even more strongly than net sales in the three-month period from July to September. Following the closing of the Versum Materials (Versum) ...

more

image description
Merck Licenses CRISPR Gene-Editing Technology to Evotec

License to accelerate research, enable testing and development of new drugs

13-Nov-2019

Merck announced that it has signed a license agreement providing Evotec SE access to Merck’s foundational CRISPR intellectual property. Evotec, an international biotechnology company headquartered in Hamburg, Germany, will use Merck’s CRISPR genome-editing technology to create edited cell lines ...

more

Curious Mind Researcher Award Granted

31-Oct-2019

Merck and the German business journal manager magazin presented the Curious Mind Researcher Award in Berlin. Ulrike Kramm (40), a materials scientist, received the prize worth €7,500 in the category “Mobility and Energy”. Computer scientist Xiaoying Zhuang (36) was also awarded € 7,500 for her ...

more

Merck Launches Seed Fund for Startups in China

RMB 100 million fund targets startups close to the three business sectors of Merck as well as new businesses

21-Oct-2019

Merck announced an RMB 100 million (€ 13 million) seed fund targeted at startups in China. The company also officially opened its innovation hub in Shanghai and announced plans to officially open a second innovation hub in Guangzhou in November. “Our RMB 100 million China seed fund underlines our ...

more

Merck Becomes the First to Use Acoustic Technology for Cell Therapy Manufacturing

Acquisition of FloDesign Sonics marks next step in autologous manufacturing

11-Oct-2019

Merck announced it has acquired FloDesign Sonics, of Wilbraham, Massachusetts, USA, developer of a unique acoustic cell processing platform for the industrialization of cell and gene therapy manufacturing. Financial details were not disclosed. “Chimeric antigen receptor T cell therapies, or CAR-T ...

more

Merck on Track to Deliver Sustainable Profitable Growth

12-Sep-2019

Merck expects to achieve sustainable profitable growth in all three business sectors in the coming years. At its Capital Markets Day, the company informed analysts and investors about the progress it has made in implementing its strategy. “In recent years, we have rigorously positioned our ...

more

image description
David Alsteens Receives 2019 Heinrich Emanuel Merck Award for Analytical Science

06-Sep-2019

Merck presented Professor David Alsteens (33), Catholic University of Louvain (UCLovain), Louvain-la-Neuve, Belgium with the 2019 Heinrich Emanuel Merck Award for Analytical Science. The award ceremony took place during the analytical conference Euroanalysis at Istanbul University in ...

more

Merck Sees Profit Jump in Q2

Net sales growth thanks to organic performance

09-Aug-2019

Merck generated strong net sales growth in the second quarter of 2019, primarily on an organic basis. EBITDA pre grew very strongly and was also driven by organic performance. Merck confirmed its full-year forecast for 2019. “We achieved sales growth in all business sectors and regions. The jump ...

more

Merck Acquires laboratory informatics company

07-Aug-2019

Merck has acquired BSSN Software, a Darmstadt, Germany-based laboratory informatics company that makes data more readily accessible for ease of integration, collaboration, analysis and long-term archiving. Financial details were not disclosed. “BSSN Software and the capabilities that it brings ...

more

image description
Merck and Broad Institute Announce CRISPR License Framework to Encourage Innovation

19-Jul-2019

Merck and the Broad Institute of MIT and Harvard (Boston, Massachusetts) announced an agreement to offer non-exclusive licenses to CRISPR intellectual property (IP) under their respective control for use in commercial research and product development. “Together with the Broad Institute, we are ...

more

Page 1 From 38
Subscribe to e-mail updates relating to your search

You will receive via e-mail the latest search results matching your search criteria. This service is free of charge and can be cancelled at any time.

Your browser is not current. Microsoft Internet Explorer 6.0 does not support some functions on Chemie.DE